MYOVIEW
Biological
GE HEALTHCARE
Total Payments
$26,336
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $25,000 | 1 | 0 |
| 2019 | $735.78 | 1 | 0 |
| 2017 | $600.00 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $25,736 | 2 | 97.7% |
| Space rental or facility fees (teaching hospital only) | $600.00 | 1 | 2.3% |
Payments by Type
Research
$25,736
2 transactions
General
$600.00
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| THE FEASIBILITY AND IMPORTANCE OF IMMEDIATE POST-STRESS IMAGING WITH TETROFOSMIN IN THE ERA OF COVID-19 | GE HEALTHCARE | $25,000 | 0 |
| BRAIN-HEART CONNECTION IN TAKOTSUBO CARDIOMYOPATHY | GE HEALTHCARE | $735.78 | 0 |
Top Doctors Receiving Payments for MYOVIEW
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $26,336 | 3 |
Ad
Manufacturing Companies
- GE HEALTHCARE $26,336
Product Information
- Type Biological
- Total Payments $26,336
- Total Doctors 0
- Transactions 3
About MYOVIEW
MYOVIEW is a biological associated with $26,336 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.
Payment data is available from 2017 to 2020. In 2020, $25,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for MYOVIEW is "Unspecified" ($25,736, 97.7% of total).
MYOVIEW is associated with 2 research studies, including "THE FEASIBILITY AND IMPORTANCE OF IMMEDIATE POST-STRESS IMAGING WITH TETROFOSMIN IN THE ERA OF COVID-19" ($25,000).